BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17526755)

  • 1. Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria.
    Sandrini MP; Shannon O; Clausen AR; Björck L; Piskur J
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2726-32. PubMed ID: 17526755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner.
    Sandrini MP; Clausen AR; On SL; Aarestrup FM; Munch-Petersen B; Piskur J
    J Antimicrob Chemother; 2007 Sep; 60(3):510-20. PubMed ID: 17615154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine is active against clinical multiresistant Staphylococcus aureus strains and is synergistic with gentamicin.
    Jordheim LP; Ben Larbi S; Fendrich O; Ducrot C; Bergeron E; Dumontet C; Freney J; Doléans-Jordheim A
    Int J Antimicrob Agents; 2012 May; 39(5):444-7. PubMed ID: 22445492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.
    Gilmer DB; Schmitz JE; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2743-50. PubMed ID: 23571534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pasteurella multocida thymidine kinase 1 efficiently activates pyrimidine nucleoside analogs.
    Clausen AR; Al Meani SA; Piskur J
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):359-62. PubMed ID: 20544520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antibacterial activity of a new 3-azinomethyl-rifamycin.
    Strippoli V; Bruzzese T; Galli R; Simonetti N; Tronci N
    Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.
    Hegde SS; Okusanya OO; Skinner R; Shaw JP; Obedencio G; Ambrose PG; Blais J; Bhavnani SM
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1578-83. PubMed ID: 22155835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriology and antibiotic susceptibility pattern of peritonsillar abscess.
    Acharya A; Gurung R; Khanal B; Ghimire A
    JNMA J Nepal Med Assoc; 2010; 49(178):139-42. PubMed ID: 21485600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes.
    Boon RJ; Beale AS
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1204-9. PubMed ID: 3307617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin infections due to Staphylococcus aureus and Streptococcus pyogenes].
    Arata J
    Nihon Rai Gakkai Zasshi; 1996 Jul; 65(2):83-7. PubMed ID: 8810559
    [No Abstract]   [Full Text] [Related]  

  • 14. Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus.
    Porter MC; Henderson BA; Healy PE; Coombs GW; Ingram PR; McLellan D; Clark B
    J Antimicrob Chemother; 2014 Mar; 69(3):856-7. PubMed ID: 24164721
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current data on antibiotic sensitivity of microflora causing otorhinolaryngologic diseases. 1. Antibiotic sensitivity of Staphylococci and Streptococci].
    Povolotskiĭ IaL
    Zh Ushn Nos Gorl Bolezn; 1979; (1):83-9. PubMed ID: 375612
    [No Abstract]   [Full Text] [Related]  

  • 16. Hybrid donor-acceptor polymer nanoparticles and combination antibiotic for mitigation of pathogenic bacteria and biofilms.
    Yates-Alston S; Sarkar S; Cochran M; Kuthirummal N; Levi N
    J Microbiol Methods; 2021 Nov; 190():106328. PubMed ID: 34536464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial deoxyribonucleoside kinases are poor suicide genes in mammalian cells.
    Hébrard C; Cros-Perrial E; Clausen AR; Dumontet C; Piskur J; Jordheim LP
    Nucleosides Nucleotides Nucleic Acids; 2009 Nov; 28(11):1068-75. PubMed ID: 20183574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Peptide Induced-Stress Renders
    Rodríguez-Rojas A; Nath A; El Shazely B; Santi G; Kim JJ; Weise C; Kuropka B; Rolff J
    Front Immunol; 2020; 11():1686. PubMed ID: 33133056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan.
    Watanabe S; Ohnishi T; Yuasa A; Kiyota H; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Manabe M; Suzuki T; Otsuka F; Aihara M; Iozumi K; Tamaki T; Funada Y; Shinozaki M; Kobayashi M; Okuda M; Kikyo G; Kikuchi K; Okada Y; Takeshima M; Kaneko O; Ogawa N; Ito R; Okuyama R; Shimada S; Shimizu T; Hatta N; Manabu M; Tsutsui K; Tanaka T; Miyachi Y; Asada H; Furukawa F; Kurokawa I; Iwatsuki K; Hide M; Muto M; Yamamoto O; Niihara H; Takagaki K; Kubota Y; Sayama K; Sano S; Furue M; Kanekura T
    J Infect Chemother; 2017 Aug; 23(8):503-511. PubMed ID: 28645883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus versus Streptococcus pyogenes in hand infection.
    Lebowitz D; Müller CA; Balagué N; Vostrel P; Beaulieu JY; Uçkay I
    Infect Dis (Lond); 2015; 47(10):747-8. PubMed ID: 25990679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.